BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.510
+0.040 (2.72%)
Dec 3, 2025, 2:21 PM EST - Market open
BioVie Market Cap
BioVie has a market cap or net worth of $11.38 million as of December 3, 2025. Its market cap has decreased by -79.86% in one year.
Market Cap
11.38M
Enterprise Value
-13.34M
1-Year Change
-79.86%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $11.38M, a decrease of -78.11%. That is a compound annual growth rate of -25.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 11.10M | -68.73% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 947.22B |
| Johnson & Johnson | 494.72B |
| AbbVie | 397.86B |
| UnitedHealth Group | 292.78B |
| AstraZeneca | 283.73B |
| Merck & Co. | 252.74B |
| Novartis AG | 249.18B |
| Abbott Laboratories | 222.59B |